microRNA Regulation of The Cocaine Effects on the Cardiovascular System
Project Number5I01BX004870-03
Contact PI/Project LeaderDONG, CHUNMING
Awardee OrganizationMIAMI VA HEALTH CARE SYSTEM
Description
Abstract Text
Despite the opioid overdose crisis, cocaine remains a widely abused illicit drug by the public and
by veterans. While opioid overdose primarily causes respiratory failure, cocaine abuse is mainly
associated with cardiovascular (CV) toxicities, which include hypertension (HTN), aortic stiffness,
and atherosclerosis. Indeed, cocaine abuse represents a significant CV risk for the general
population and for veterans. It is known that cocaine stimulates the sympathetic nervous system
(SNS) by inhibiting norepinephrine (NE) reuptake at nerve terminals; however, recent evidence
suggests that inhibition of NE reuptake may not be the major driver of cocaine-induced HTN. As
such, the mechanisms mediating the effects of cocaine on the CV system remain largely unknown.
To that end, we recently performed small RNA and RNA sequencing in the aortas from mice
treated with cocaine, cocaine methiodide (CM, which does not enter the central nervous system),
or saline to identify potential microRNA (miR)—mRNA pathways that mediate the CV effects of
cocaine. Nine miR—mRNA pathways were implicated. We prioritized and identified two miR-
mRNA axes based on their levels of expression changes and relevance to CV physiology. They
are: 1) the ↑miR-30c—↓Malic Enzyme 1 (ME1)—↑reactive oxygen species (ROS) activity, which
is crucial in HTN and vascular aging (aortic stiffness); and 2) the ↓miR-423—↑Cacna2d2
(encoding the α2δ-2 subunit of voltage-dependent calcium channels) —↑calcium influx resulting
in increased intracellular calcium concentration ([Ca2+]i) which is critical in controlling vascular
smooth muscle cell (SMC) contractility and blood pressure (BP). We thoroughly investigated the
miR-30c pathway and recently published our findings in the journal Hypertension. In preliminary
studies, we showed that cocaine- and CM-induced silencing of miR-423-5p expression and
subsequent upregulation of Cacna2d2 led to increased [Ca2+]i, which augmented contractility in
cultured SMCs. Furthermore, miR-423-5p overexpression ameliorated cocaine-induced BP
elevation in vivo. Interestingly, miR-423-5p has been associated with heart failure and coronary
artery disease. Its role in the pathogenesis of HTN remains unknown. Based on our published
work and preliminary studies, we hypothesize that the miR-423—Cacna2d2 axis plays an
important role in cocaine-induced HTN by regulating calcium influx and intracellular
calcium concentrations ([Ca2+]i) in vascular cells. In addition, recent studies support a strong
crosstalk between these two biological processes—Ca2+ signaling and ROS. We have pilot data
showing that modification of both miR axes largely abrogated cocaine-induced SMC contraction.
Therefore, we further hypothesize that these two pathways work synergistically to mediate
cocaine-induced CV consequences. We will thoroughly characterize the ↓miR-423-5p—
↑Cacna2d2—↑ [Ca2+]i axis and its interaction with the ↑miR-30c—↓ME1—↑ROS pathway in
mediating the effects of cocaine on the CV system by using complimentary and vertically
integrated in vitro, ex vivo, and in vivo models. In addition, we will measure NE and its metabolite
levels, as well as use Prazosin (an -blocker) to block the effects of NE in the in vivo experiments,
aiming to characterize the potential interplay between the miR-mRNA axes and SNS in mediating
the CV effects of cocaine.
Public Health Relevance Statement
Veterans of war are more prone to be affected by depression, chronic fatigue and anxiety.
Posttraumatic stress disorder (PTSD) is common among former soldiers who have experienced
traumatic battlefield combat experiences, such as witnessing suffering and death. Although there
are several factors that predict the severity of symptoms and recovery, PTSD is undoubtedly a
widespread condition among soldiers. Research suggests that there is a specific link between
PTSD and cocaine abuse and that patient treatment should approach both disorders in order to
be successful. This proposal focuses on characterizing the molecular mechanisms involved in the
effects of cocaine in the cardiovascular system. This will help inform patient care and facilitate
the development of novel therapeutic treatments for cocaine-induced cardiovascular toxicities for
veterans in particular, among whom cocaine abuse is more prevalent.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccountingAcetylcysteineAdrenergic AgentsAffectAgingAnxietyAortaArrhythmiaAtherosclerosisBiological ProcessBlood PressureBlood VesselsCalciumCalcium ChannelCardiac Catheterization ProceduresCardiovascular DiseasesCardiovascular PathologyCardiovascular PhysiologyCardiovascular systemCatecholaminesCause of DeathCell physiologyCellsCentral Nervous SystemCessation of lifeChronicCocaineCocaine AbuseComplexCoronary ArteriosclerosisDataDevelopmentDiseaseEmergency department visitEnsureEpidemiologyFDA approvedFatigueFloridaFundingGeneral PopulationGenesGenomic approachGuidelinesHeart failureHypertensionIllicit DrugsIn VitroJournalsLinkMeasuresMediatingMental DepressionMessenger RNAMicroRNAsModificationMolecularMusMuscle ContractionNerveNerve EndingsNimodipineNorepinephrineOpioidOutcomePathogenesisPathologicPathway interactionsPatient CarePatientsPlayPost-Traumatic Stress DisordersPrazosinPredictive FactorPrevalencePublishingReactive Oxygen SpeciesRecoveryRegulationReportingResearchResearch DesignResourcesRespiratory FailureRoleSalineSeveritiesSignal TransductionSmall RNASmooth Muscle MyocytesSoldierSolidSympathetic Nervous SystemSymptomsTestingToxic effectTreatment-related toxicityUnited States National Institutes of HealthUp-RegulationVascular Endothelial CellVascular Smooth MuscleVeteransVisitWarWorkanalogblood pressure elevationcardiovascular effectscardiovascular risk factorclinical practicecocaine exposurecocaine usecombatexperienceexperimental studygenomic dataillicit drug usein vitro Modelin vivoin vivo Modelinnovationmalic enzymenovel therapeuticsopioid epidemicopioid overdoseoverexpressionpharmacologicrespiratoryreuptaketranscriptome sequencingtranslational potential
No Sub Projects information available for 5I01BX004870-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5I01BX004870-03
Patents
No Patents information available for 5I01BX004870-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5I01BX004870-03
Clinical Studies
No Clinical Studies information available for 5I01BX004870-03
News and More
Related News Releases
No news release information available for 5I01BX004870-03
History
No Historical information available for 5I01BX004870-03
Similar Projects
No Similar Projects information available for 5I01BX004870-03